(Bloomberg) Elon Musk’s net worth is soaring after it plunged to the lowest level in almost a year.Most Read from BloombergTesla Soars on Tentative China Approval for Driving SystemStocks Trade for 390 Minutes a Day. Increasingly, Only 10 MatterYen Sparks Intervention Suspicion After U-Turn From 1990 LowsWhat 60,000 Headlines Say About the Fed’s Next MoveElliott Built ‘Large’ Stake in Buffett-Favored Sumitomo, Source SaysIn the past five days, the world’s third-richest person has gained $37.3
Musk's Fortune Soars by Most Since Before Twitter Purchase bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
The FDA was expected to make its decision by Wednesday, but it is still reviewing Liquidia's marketing application for possible approval, although it has not asked for any additional clinical data to support the application. The North Carolina-based company was seeking the health regulator's nod to expand the use of its drug to also treat pulmonary hypertension associated with interstitial lung disease (PH-ILD), a group of disorders that cause scarring in the lungs. The drug was granted tentative approval in 2021 to treat pulmonary arterial hypertension (PAH) to improve adult patients' ability to exercise.